Administration of monoclonal antibodies against respiratory viruses
CA 2040770 A1 · Owner: Prince, Gregory A. · Inventors: Young, James F.; Prince, Gregory A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A process for the prophylaxis and/or treatment of respiratory viruses which comprises administering topically or systemically to an, animal, at least one monoclonal antibody against at least one respiratory virus. The present invention is particularly applicable to the prophylaxis of respiratory syncytial virus, or RSV by administering at least one, monoclonal antibody against a fusion protein of respiratory syncytial virus .
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 18, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 18, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 18, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.